2001
DOI: 10.1212/wnl.57.8.1416
|View full text |Cite
|
Sign up to set email alerts
|

Randomized trial of vigabatrin in patients with infantile spasms

Abstract: These results confirm previous reports of the efficacy and safety of vigabatrin in patients with infantile spasms, particularly among those with spasms secondary to tuberous sclerosis.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

6
146
1
6

Year Published

2002
2002
2014
2014

Publication Types

Select...
3
3

Relationship

0
6

Authors

Journals

citations
Cited by 206 publications
(159 citation statements)
references
References 26 publications
6
146
1
6
Order By: Relevance
“…In the study of 179 infants by Elterman et al [40] (Class III), which also included video EEG, the response rates with vigabatrin were very similar to the Finnish study: 23 % at day 14 but 60 % at 3 months. Thus, the response to vigabatrin seems to come later and in fewer infants than ACTH.…”
Section: Is Acth More Effective Than Vigabatrin For Shortterm Treatmesupporting
confidence: 54%
See 4 more Smart Citations
“…In the study of 179 infants by Elterman et al [40] (Class III), which also included video EEG, the response rates with vigabatrin were very similar to the Finnish study: 23 % at day 14 but 60 % at 3 months. Thus, the response to vigabatrin seems to come later and in fewer infants than ACTH.…”
Section: Is Acth More Effective Than Vigabatrin For Shortterm Treatmesupporting
confidence: 54%
“…Thus, the response to vigabatrin seems to come later and in fewer infants than ACTH. Large doses of vigabatrin (100-140 mg/kg/day) were more effective than the small doses (18-36 mg/kg/ day) in the study by Elterman et al [40,41].…”
Section: Is Acth More Effective Than Vigabatrin For Shortterm Treatmementioning
confidence: 80%
See 3 more Smart Citations